Formerly stealthy startup UNandUP is headed to a huge conference next week.
Francis “Duke” Creighton, UNandUP CEO
“The American Heart Association and the International Stroke Conference… in partnership with the National Institutes of Health… has selected us to be one of the eight companies presenting at their innovation showcase,” Francis ‘Duke’ Creighton told bizblip. “We got our first patent August 9, last year, and have several more in process… we’re executing upon four new technologies, which are summarized on our new website.”
The startup is developing a robotic system to better treat heart arrhythmia. Supported, in part, by BioSTL/BioGenerator, project partners include doctors Mitch Faddis and Jen Silva from Washington University and doctor Sandeep Jane at UPMC in Pittsburgh. UNandUP is also partnered with two national laboratories: the Ames National Laboratory and the National High Magnetic Field Laboratory.”
Racking up SBIR grants since 2019, with seven Phase 1’s and two Phase 2’s, UNandUP emerged from stealth mode last October to talk with bizblip publisher Paul Riat about the most recent $1.1 million grant from the National Heart, Lung and Blood Institute… part of the NIH. Counting that grant the startup has brought in more than $3M in SBIR money, plus six diversity supplements from the NIH.
The company has four full time employees and recently moved from the CIC in downtown St. Louis to a 3000 square foot space in Midtown, near Wells Fargo.
Links:
